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Injected-ion mobility and high-pressure ion mobility techniques have been used to examine
the conformations of bradykinin, insulin chain A, and several other peptide ions in the gas
phase. Under the experimental conditions employed, evidence for multimer formation in the
mass spectra of peptides is minimal or absent altogether. However, ion mobility distributions
show that aggregates of peptides (containing a single charge per monomer unit) are observed
at the same mass-to-charge ratios as the singly charged parent ions. Collision cross sections for
these clusters show that they have tightly packed roughly spherical conformations. We
have bracketed the average density as 0.87 , r , 1.00 g cm23. In some cases, specific stable
aggregate forms within a cluster size can be distinguished indicating that some high order
structures are favored in the gas phase. Multimer formation between different sizes of
polyalanine peptides shows no evidence for size specificity in aggregate formation. Collisional
and thermal excitation studies have been used to examine structural transitions and dissoci-
ation of the multimers. Aggregates appear to dissociate via loss of singly charged monomers.
The observation that peptide multimers can be concealed in mass spectral data requires that
fragmentation patterns and reactivity studies of singly charged monomers be undertaken with
care. (J Am Soc Mass Spectrom 1998, 9, 743–759) © 1998 American Society for Mass
Spectrometry
Observations of noncovalently bound complexesand multimers [1–21] formed by electrosprayionization [22] (ESI) have stimulated interest in
the high-order structures of biomolecules in the gas
phase [23]. In some cases there is evidence that highly
specific noncovalent interactions that are present in
solution are preserved in the gas phase [2–13, 15–17],
while in other systems, nonspecific aggregates appar-
ently form in the electrosprayed droplet [1, 14, 19].
Many exciting experiments appear to be accessible from
studies of noncovalent associations of ESI ions, includ-
ing solution enzyme/substrate, antibody/epitope, and
receptor/ligand binding studies as well as the potential
of stabilizing conformations or complexes in the gas
phase that are atypical of those found in solution [11].
Studies of high-order biomolecular structures are lim-
ited because of the dearth of experimental options for
probing these transient species in vacuo.
In this article we have used injected-ion mobility and
high-resolution ion mobility techniques [24–27] to in-
vestigate the high-order structures and dissociation of
multiply charged peptide aggregates, containing from
two to six monomer units. Ion mobility measurements
allow information about the average shapes of biomol-
ecules to be directly determined [24e, 25, 28, 29]. In the
systems studied here, we find that the aggregates have
compact, roughly spherical structures. In some cases,
we find evidence for many stable aggregate conforma-
tions within a cluster size. This article presents the first
direct look at the shapes of clusters of biomolecular
ions.
Our initial intent in investigating peptide ions was to
examine the relationship of peptide sequence to confor-
mation in the absence of solvent. We briefly discuss
monomer conformations below; however, this is not the
focus of this article. As studies of several peptide
systems progressed, it became clear that efforts were
necessary to avoid multimer formation. In many cases
our observations of aggregates in ion mobility data
were surprising because the mass spectra exhibited
little or no evidence for multimers. Below, we show that
for some systems under the source conditions em-
ployed, most of the ion signal that is normally attrib-
uted to singly charged monomers is actually because of
a series of related aggregates having a single charge per
monomer unit.
Mass spectrometry (MS)-based strategies for rapidly
deducing sequence information have become an impor-
tant means of identifying unknown peptides and pro-
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teins [30]. A number of elegant studies have investi-
gated the details of peptide and protein dissociation by
using thermal, photon, and collisional activation meth-
ods [31]. The observation that peptide aggregates can be
concealed in MS data should be of interest to these
studies as the precursor state could influence energy
deposition and fragmentation pathways.
In addition to ion mobility methods [24, 25, 28, 29], a
number of MS-based methods have recently been used
to investigate biomolecular conformations in vacuo.
These include ion scattering experiments in triple quad-
rupole instruments [32]; kinetic energy release measure-
ments [33]; microscopy studies of surfaces bombarded
with high energy ions [34]; measurements of gas-phase
H/D exchange levels [18, 35] and gas-phase basicities
[36]; and studies of adduct formation [37, 38].
Experimental
General
Detailed discussions of ion mobility/MS methods [24]
and their applications to biomolecules [25, 26, 28, 29]
have been given previously. Only a brief description is
given here. Two ion mobility configurations are utilized
in these studies: an injected-ion configuration, in which
ions are extracted into a high vacuum region and
injected into the entrance of the drift tube at variable
kinetic energies; and, a high-pressure configuration in
which ions enter a drift region without being extracted
into a high-vacuum region. Schematic diagrams of both
instruments are shown in Figure 1. In both configura-
tions, ion mobility distributions are recorded by mea-
suring the time required for a pulse of ions to travel
across a well-defined drift region under the influence of
a uniform electric field. Ions that exit the drift tube are
focused into a mass spectrometer and detected by using
an off-axis collision dynode detection system. Two
vacuum chambers are used to house the instruments: a
main chamber that houses and aligns all components of
the ion mobility instrument and a detector chamber that
contains the mass spectrometer, several focusing ele-
ments, and the detection system. For most of the studies
reported here, ions of a known mass-to-charge are
selected by a quadrupole mass filter. As discussed
below, we have also used a time-of-flight instrument to
perform measurements of mass-to-charge selected mo-
bility distributions for mixtures of ions.
Injected-Ion Configuration
The injected-ion instrument has been described previ-
ously [29]. Briefly, ions are formed by electrospraying
solutions at atmospheric pressures into a variable tem-
perature differentially pumped desolvation region
(;2–10 torr). Ions exit this region through a 0.04-cm-
diameter orifice into a high-vacuum region (1025 to
1024 torr) where they are focused by a series of electro-
static lenses and accelerated to a desired kinetic energy.
Figure 1. Schematic diagram of the injected-ion and high-pressure instrumental arrangements used
for these studies. The mass filter and detector depicted in the top schematic are the same for both
configurations.
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Ion pulses (20 to 50 ms in duration, obtained by varying
the potential of a deflector in the lens system) are
injected through a 0.020-cm-diameter aperture into the
drift tube containing from ;1 to 5 torr of He buffer gas.
The ion charge state and voltage difference between the
exit of the high-pressure source and the drift tube
entrance flange define the injection energy. The drift
tube used in these studies is 35.15 cm long and 30
equally spaced electrostatic lenses ensure a uniform
electric field along the drift axis. In these experiments,
drift fields ranging from ;3 to 15 V cm21 were used.
The maximum drift field is limited by the breakdown
voltage of the He buffer gas, which is near the maxi-
mum fields used for these studies at these pressures.
As ions enter the drift tube, they are rapidly heated
as their kinetic energies are thermalized by collisions
with the buffer gas. Further collisions cool the ions to
the temperature of the gas. This heating/cooling cycle
can be varied by changing the injection voltage and is
the basis for a straightforward approach for examining
structural transitions [25, 28, 29, 39] and dissociation
pathways of biomolecules [40]. In many systems it is
desirable to inject ions at the lowest possible injection
energy in order to examine conformations that are
formed in the ion source. Attempts to characterize
source conformations are limited by a minimum injec-
tion energy that is required to overcome the flow of
buffer gas out of the drift tube entrance aperture; for
most large molecules, ion signals decrease rapidly at
injection voltages below ;50 V.
High-Pressure Configuration
Several recent studies have described high pressure
drift tubes equipped with ESI sources [41]. In our
instrument, the main vacuum chamber is designed in a
modular fashion such that the high-pressure drift tube
replaces the variable-temperature desolvation region,
ion lenses, and drift tube of the injected ion instrument.
Both configurations utilize the same buffer gas inlet
systems and are aligned with the quadrupole using two
V-block stands that are mounted to the chamber. It is
possible to convert between the two instrumental con-
figurations in a few hours.
The drift tube body is comprised of 2.5-cm-thick
copper rings (12.7 and 15.2 cm inner and outer diame-
ters, respectively) separated by 0.9-cm-thick ceramic
spacers machined from mycalex (McMaster Carr, Chi-
cago, IL). The copper/mycalex ring system is sealed by
indium or silver wire, or viton O-rings, creating a sealed
cavity that can be filled with buffer gas. The copper
electrodes are designed to accept cartridge heaters,
permitting temperature dependent studies. The drift
region is 48.74 cm in length and is defined by the ion
gate and exit of the drift tube. The drift field is created
by voltages applied to the copper rings that are con-
nected by a series of 5 MV high vacuum resistors
(KDI/Triangle, Whippany, NJ, 1%). Calculations of the
equipotential lines [42] created by using this geometry
show that the drift field is highly uniform along the
drift axis, an important criterion for recording high-
resolution ion mobility distributions [24d].
Ions are electrosprayed at atmospheric pressures
directly into a differentially pumped desolvation region
(analogous to the source described above) through a
17.8-cm-long, 0.16-cm-diameter capillary tube. The en-
trance of the tube protrudes into a plexiglass chamber
that can be pressurized with He gas as shown in Figure
1. Ions are forced through the tube by the pressure
gradient across the capillary.
The capillary extends into the center of a series of 10
BeCu lenses separated by 0.1-in.-thick Teflon spacers.
The lenses and spacers create a 0.2-cm-diameter chan-
nel that is ;2.5 cm long; most of the He buffer gas is
pumped away through this region by the differentially
pumped ion source. We estimate that the pressure in
the differential pumping region is ;150–200 torr. The
lenses are connected by a series of resistors in order to
create a uniform electric field and the voltage drop
across these lenses is ;1000–2000 V. This guides the
ions from the source into the body of the drift tube
against the counterflow of He buffer gas, while prevent-
ing neutrals from entering the drift region [27].
Once inside the body of the drift tube, the ions drift
through the buffer gas under the influence of a field
provided by the copper ring electrodes until reaching a
wire gate. A variety of gating configurations can be
used to cut a pulse of ions; the results reported here
were obtained with a gate that is similar in design to
one discussed previously by Hill and co-workers [24d].
The gate was constructed by stringing wire (nickel/iron
alloy) to form sets of alternating, parallel rows spaced
0.07 cm apart on a fiberglass support. Opposite polarity
voltage pulses are applied to the wires in order to
introduce short pulses of ions into the drift tube. The
pressure of the He buffer gas was ;200 torr in these
experiments.
Ion Mobility/Time-of-Flight Mass Spectrometry
Measurements
We have recently developed an ion mobility/time-of-
flight (TOF) mass spectrometer that allows mass-
resolved ion mobility distributions for large arrays of
ions to be recorded simultaneously. A detailed descrip-
tion of this instrument has been given elsewhere [43].
Only a brief description is given here. Figure 2 shows a
schematic diagram of this apparatus. Ions drift through
the ion mobility instrument and are focused into the
entrance region of a linear time-of-flight mass spec-
trometer. A series of lenses (G1–G4) are used to pulse
and accelerate ions into a 43.2-cm-long field-free region
for TOF analysis.
Because flight times in the mass spectrometer are
much shorter than drift times in the ion mobility
instrument, it is possible to record mass spectra within
each drift time window. This allows mass resolved ion
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mobility distributions to be recorded simultaneously
for arrays of ions that are produced by ESI. In the
present study we have utilized the injected ion drift
tube and ESI source described above for the mobility
measurements. An important advantage of this ap-
proach is that it facilitates direct measurements of
mobility and mass resolved ion abundance for the
system of ions.
Figure 2b shows a typical pulse sequence for initial
injection of ions into the drift tube followed by time-of-
flight analysis. Ions are injected into the drift tube at a
repetition rate of 30 Hz and into the flight tube at 104
Hz. The initial injection pulse activates a programmable
delay generator (PDG, Lecroy 4222) and pulse sequence
that triggers a high voltage time-of-flight pulser at
specified delay times. Flight times in the mass spec-
trometer are recorded by using a time-to-digital con-
verter (TDC, Lecroy 4208) that is also initiated by the
PDG pulse sequence. The instrumental electronics and
data acquisition system are synchronized by an inter-
face and controlled by a computer.
Electrospray of Peptides
We have examined four peptides individually in this
study: bradykinin (BK) (Sigma 98%, MW 5 1060); and
insulin chain A (ICA) [44] [Sigma .80%, molecular
weight (MW) 5 2532]; LG6 (TRQARRNAAAAWRE
RQR, MW 5 2052) and LG7 (TRQARRNRRRRAAA
AAA, MW 5 1952), which were synthesized by using a
peptide synthesizer (Rainin, model PS3). Additionally,
a range of polyalanine peptides were studied by elec-
trospraying a mixture of peptides of varying sizes
(Sigma, 1000–5000 MW). Positively charged (proton-
ated) and negatively charged (deprotonated) peptide
ions were formed by electrospraying solutions contain-
ing ;3 3 1025 to 1 3 1023 M peptide in either 49:49:2
water:acetonitrile:acetic acid or 49:49:2 water:acetoni-
trile:ammonium hydroxide, respectively.
Collision Cross Sections
In all of the configurations described above, the time
required for ions to reach the detector is a composite of
the drift time and time required for ions to travel
through other portions of the instrument. Thus, it is
necessary to account for the flight times of ions when no
gas is present as well as for differences in the ions’
energies at the exit of the drift tube in the presence and
absence of buffer gas. These corrections are small
(;150–250 ms for ions in the quadrupole-based instru-
ment and ;80–140 ms in the TOF instrument). Compact
conformers have larger mobilities (and smaller collision
cross sections) than more diffuse ones. The reduced









Figure 2. (a) Schematic diagram of the ion mobility/TOFMS instrument. (b) Pulse sequence used to
record a three dimensional spectrum of drift times, flight times, and ion abundance for multiple
mass-to-charge ions simultaneously.
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where the measured parameters tD, E, L, P, and T
correspond to the average drift time, the electric field
strength, the drift tube length, buffer gas pressure (in
torr), and temperature, respectively. Experimental col-
lision cross sections are obtained directly from the ion

















which contains the mobility expression. The other terms
are as follows: ze, the ion’s charge; N, the neutral
number density; kb, Boltzmann’s constant; and mI and
mB, the masses of the ion and buffer gas, respectively.
The parameters E, L, P, and tD can be precisely
measured such that the reproducibility of mobilities
and cross sections is excellent. Any two measurements
recorded on the same instrument typically agree to
within 1% (percent relative uncertainty).
Cross sections measured with different instruments
agree to within 2%. The present experiments were
carried out at low E/N where mobilities are indepen-
dent of the applied drift field and drift velocities are
small compared with the thermal velocity of the buffer
gas. Under these conditions, ions are not expected to
align in the drift tube. Reduced mobilities for all peaks
measured over a range of drift fields from 3–15 (inject-
ed-ion) and 20–200 V cm21 (high pressure) are identical
within the experimental uncertainties. Thus, there is no
evidence that ions align in the drift tube and we assume
that cross sections correspond to an average of all
possible orientations.
Structural information for different ions is obtained
by comparing the experimental cross sections with
cross sections that are calculated for atomic coordinates
of trial conformations. Here, collision cross sections for
trial structures are estimated by determining the orien-
tationally averaged projection by using a method that is
analogous to those described previously [24e, 25]. The
reported values are an average of 104 to 105 random
orientations. This method treats the interactions be-
tween atoms of the biomolecule and the buffer gas as
hard-sphere collisions and assumes a rigid trial confor-
mation. The values that are obtained depend slightly
upon the hard-sphere diameters of the colliding part-
ners and this approach is generally believed to provide
a lower limit to the true collision integral. We have used
diameters of 2.2 Å for He and H, and values of 3.1, 2.8,
2.7, and 3.1 Å for C, N, O, and S, respectively. Recently,
methods for calculating cross sections for very large
molecules have been scrutinized and attempts to in-
clude more realistic potential interactions and scattering
trajectories in calculations of biomolecular cross sec-
tions have been made [46]. Shvartsburg and Jarrold
have developed an exact hard sphere scattering model
(generally viewed as an upper limit) that rigorously
accounts for momentum transfer associated with scat-
tering of the buffer gas [47]. Cross sections from this
method are ;12 to 15% higher (for elongated and
compact conformations, respectively) than values ob-
tained from the projection method.
Theoretical Resolving Power
The ability to resolve two conformers having different
collision cross sections is given by [48]
tD
Dt
< F LEze16kbT ln 2G
1/2
(3)
where Dt is the width of the drift time peak at half
maximum. In the present experiments, we have used
drift fields ranging from ;3 to 15 V cm21 in the
injected-ion instrument and ;20 to 200 V cm21 in the
high pressure instrument. The drift field is ultimately
limited by the discharge potential of the buffer gas at a
given operating pressure.
A measure of the theoretical resolving power can be
obtained from calculated distributions for the transport
of a single geometric structure through the drift tube.
This is given by [45]
F~t! 5 E C~Dt!1/2 ~nD 1 L/t!F1 2 expS2r024Dt DG
exp S2~L 2 nDt!24Dt D P~tp!dtp (4)
where F(t) is the intensity of ions passing through the
exit aperture as a function of time, r0 is entrance
aperture radius, nD is the measured drift velocity, C is a
constant, P(tp)dtp is the distribution function for the
pulse of ions entering the drift tube, and D is the
diffusion constant [49]. Comparisons of calculated dis-
tributions to experimental peaks provide information
about the number of different conformations that are
present. Experimental peaks that are significantly
broader than the calculated distribution indicate either
that multiple conformations exist or that conformers
interconvert as they travel through the buffer gas. Close
agreement between the calculated and experimental
peaks suggests that only a single conformation is
present. However, we cannot rule out the possibility
that multiple conformations with identical mobilities
are present.
Results
Similarity of Different Peptide Systems
The results discussed below focus on the BK and ICA
systems. It is important to note that detailed studies of
BK, ICA (as protonated and deprotonated ions), LG6 (as
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protonated ions), and LG7 (as deprotonated ions) show
similar behavior to the results that are shown.
Peptide Mass Spectra
Figure 3 shows example mass spectra for protonated BK
and deprotonated ICA ions recorded by using the
injected-ion mobility apparatus. Peaks for BK at m/z
values of 354, 531, and 1061 are consistent with forma-
tion of triply, doubly, and singly protonated peptide
ions, respectively [50]. A very small peak at m/z 708 is
consistent with formation of a triply protonated dimer
ion [M213H]
31. Peaks in the mass spectrum for ICA at
m/z 5 843, 1265, and 2531 are consistent with forma-
tion of the deprotonated [M–3H]32, [M–2H]22, and
[M–H]2 ions, respectively. In several other ICA mass
spectra (not shown) we have observed peaks in the
mass spectra that can be assigned to [Mn 2
(n 2 1)H](n21)2 (n 5 4 – 8) and [Mn 2 (n11)H]
(n11)2
(n 5 2– 4) ions. These peaks are extremely small
(usually less than 1% of the maximum peak height)
such that evidence in the mass spectra for multimer
formation is minimal (and often absent altogether).
Injected-Ion Mobility Distributions
Ion mobility distributions for the major peaks observed
in the mass spectra for BK and ICA are also shown in
Figure 3. In all of the systems studied here, ion mobility
distributions for doubly and triply charged monomer
ions show a single peak. Drift times decrease with
increasing charge state, a result of the larger effective
field strength (zE) experienced by higher charge state
ions. Multiple peaks are observed for m/z 5 1061 and
2531 ions of BK and ICA, respectively. The observation
of multiple peaks for these mass-to-charge ratios is
somewhat surprising, and requires that species with
very different mobilities are present.
We have numbered the peaks for the m/z 5 1061
and 2531 ions from low to high mobilities (I–VI) as
shown in Figure 3. Bowers and co-workers have previ-
ously reported a cross section of 242 Å2 for singly
protonated BK formed by matrix assisted laser desorp-
tion ionization (MALDI) [25]. From molecular modeling
studies, they concluded that this ion has a compact
conformation where the peptide has folded around the
protonation site. By using a rearranged form of eq 2 and
the 242 Å2 cross section, we calculate an expected drift
time for a singly charged compact conformation of 2.97
ms, in agreement with the peak observed at longest
times.
To obtain additional information about these ions,
we have varied the voltage that is used to inject ions
into the drift tube. Figure 4 shows ion mobility distri-
butions for the m/z 5 1061, 2531, and 1951 ions of BK,
ICA, and the LG7 peptide as a function of injection
voltage. These data are typical of results we have
obtained for all of the systems reported here. At injec-
tion voltages below the lowest values shown (60, 160,
and 70 V for the BK, ICA, and LG7 systems, respec-
tively) the distribution of peaks does not change signif-
icantly. Thus, we expect these distributions are near the
distributions of ions formed in the source. Peaks I, II,
and III are favored for BK; II, III, and IV are favored for
Figure 3. Plots on the left show ESI mass spectra for bradykinin and insulin chain A. The plot in the
middle shows ion mobility distributions for the 13, 12, and nominal 11 BK ions. The plot on the right
shows ion mobility distributions for the 23, 22, and nominal 21 charge states of insulin chain A. All
ion mobility distributions have been normalized to a buffer gas pressure of 2.000 torr and a drift field
of 12.8 V cm21. Data for bradykinin were recorded by using an injection voltage of 60 V. Data for
insulin chain A were recorded by using an injection voltage of 160 V.
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ICA; and peak IV is favored for LG7. When the injection
voltage is increased, the fraction of ions in peaks II–IV
(BK), II–VI (ICA), and III and IV (LG7) decreases. At
high injection voltages, peak I is favored for all systems.
Mass spectra recorded at these injection voltages show
no additional peaks associated with fragmentation that
can account for the large changes observed in Figure 4
[51]. The differences between low and high injection
voltage distributions must involve conversion of peaks
II–VI into peak I.
High Resolution Ion Mobility Distributions
Figure 5 shows high-resolution ion mobility distribu-
tions recorded at high pressures for m/z 5 1061 ions of
BK. The data shown were recorded by using capillary
temperatures of 300 and 450 K. Also shown are data
recorded in the injected-ion instrument that are scaled
for differences in length, pressure, and electric field
strength for comparison. Overall, the peak shapes and
positions recorded in the high-pressure instrument are
in close agreement with the injected ion data. The
primary difference between these data is the fraction of
peak I ions: 32% of the distribution for the injected ion
instrument, compared with only 7% for the high-pres-
sure instrument. This difference presumably arises be-
cause of a small degree of multimer dissociation that
occurs in the injected-ion instrument (even at the low 60
V injection voltage) that converts a small fraction of
peaks II–IV into peak I. This does not occur in the high
pressure instrument because ions are not exposed to the
injection process.
A second difference in these data is the number of
resolvable features. In the injected ion data, there are
four resolved features (peaks I–IV). All four of these
peaks are noticeably broader than the calculated distri-
butions obtained from eq 4 for transport of a single
conformation. This indicates that multiple conforma-
tions are present, but not resolved, or that structures
interconvert as they travel through the drift tube. The
region associated with peak III (from ;21 to 25 ms) is
especially broad and has a full width at half maximum
(FWHM) that is ;5 times larger than the peak calcu-
lated for a single conformer. Many additional features
can be discerned in the high resolution data. Under
similar source conditions to the injected ion experi-
ments (i.e., a capillary temperature of 300 K and iden-
tical solution composition), there are ten reproducible
local maxima in the high pressure distribution. The
region associated with peak III (from ;21 to 25 ms) is
;40 times larger than the ;0.1 ms FWHM calculated
for transport of a single conformer [52]. There are at
least four reproducible maxima within peak III and at
least three reproducible local maxima for peak IV.
Figure 5 also shows an ion mobility distribution that
was recorded at a capillary temperature of 450 K. Under
these conditions, peak IV is no longer observed, and the
relative abundance of peak III is substantially less
(;20% at 450 K compared with 35% observed at 300 K).
The absence of peak IV, decrease in peak III, and an
increased abundance of peaks I and II are all consistent
with a thermal process in the ion source that is analo-
gous to the changes induced by collisional activation
(Figure 4). Within peaks I, II, and III, there are twelve
reproducible features at 450 K. At least six reproducible
features are observed for peak III and three distinct
peaks for peak II. It is interesting that at high temper-
ature, peak II shows three distinct peaks over a 26.1 to
Figure 4. Ion mobility distributions recorded as a function of injection voltage for m/z 5 1061 ions
of bradykinin (left), m/z 5 2531 ions of insulin chain A (middle), and m/z 5 1951 ions of LG7 (right).
All spectra were normalized to a buffer gas pressure of 2.000 torr and a drift field of 12.8 V cm21.
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27.7 ms time range, whereas at room temperature, this
feature was a single narrow peak. It is possible that
these new features are produced from loss of peak IV. It
is also possible that peak II anneals into three favored
forms at higher capillary temperatures.
Ion Mobility/Time-of-Flight Measurements for a
Mixture of Polyalanine Sizes
By using the ion mobility/TOF mass spectrometer
shown in Figure 2 we have examined a mixture of
polyalanine peptides (having different lengths) in order
to rapidly assess whether the features observed for
individual peptides are general for a wide range of
peptide sizes. Figure 6a,b shows three-dimensional
plots of a drift time/time-of-flight spectrum (at two
orientations) for all ions that are observed after injecting
the electrosprayed polyalanine ions into the drift tube
with a voltage of 70 V. In this plot the ions’ flight times
(in the TOF mass spectrometer) increase from right to
left. From this orientation, we observe a series of
resolved peaks that have flight times and drift times
that increase systematically. From the flight times, we
deduce a spacing of 71 m/z (the molecular weight of a
single alanine residue) between the resolved peaks
[Figure 6(a)]. Thus, this series of peaks corresponds to
singly charged alanine peptides of varying sizes [Alan1
H]1, and from these flight times, we deduce that n
ranges from 5–30. The relative abundance of different
peptide monomers has a bell-shaped distribution that




1 size distribution is
skewed toward much smaller peptides than we ex-
pected for ESI of a mixture of peptides in the 1000 to
5000 MW range (Ala13–Ala65) of the sample. It is likely
that the smaller alanine peptides are favored by ESI
because of differences in solubility. It is also possible
that large peptide ions fragment into smaller ones on
injection; however, this is unlikely because these injec-
tion conditions are far below where we typically ob-
serve significant covalent bond fragmentation.
The orientation of the plot in Figure 6(b) shows an
additional distribution of ions. These ions have a TOF
profile that is similar to the distribution of singly
charged peptides; however, the drift times for these
ions are shifted to shorter times. A magnification of
these data [Figure 6(c)] shows individual mass spectra
recorded within individual drift time windows. This
plot shows that every other peak of the series of high
mobility ions is observed at the same mass-to-charge
units as the singly charged polyalanine peptides. Be-
tween peaks for the singly charged polyalanine pep-
tides, we observe an additional series of peaks that have
intermediate mass-to-charge spacings of ;36 and indi-
cate that this series of ions is due to a distribution of
doubly charged ions. Because polyalanine peptides
contain only a single basic site (the N-terminal amino
group), the doubly charged ions observed must corre-
spond to peptide aggregates having general formulas of
[Ala2n12H]
21 (observed at the same mass-to-charge
ratios as the [Alan1H]
1 ions) and [Ala2n1112H]
21
(observed at mass-to-charge ratios between the [Alan1
H]1 peaks). Here, n ranges from ;9 to 22 for the doubly
charged dimer ions. The ability to resolve the [Ala2n111
2H]21 in the mass spectrum and the clear correlation in
drift times of these ions with the higher mobility peaks
that we assign to [Ala2n12H]
21 ions further corrobo-
rates the assignment of higher mobility ions to multiply
charged multimers in these systems.
In some cases, we observe a third feature in the data
that shows up as a low intensity unresolved feature that
is broadly distributed over a wide range of drift and
flight times. The present data show that this broad
feature is centered near a flight time of ;15 ms (m/z ;
1200) and a drift time of ;3 ms. These ions are not
easily assigned because the peak is poorly resolved. The
peak may correspond to a system of larger aggregates
or to partially solvated ions.
Figure 5. Comparison of ion mobility distributions recorded by
using the injected ion instrument and the high-pressure drift tube
for m/z 5 1061 ions of bradykinin. The bottom spectrum shows
data recorded in the injected ion instrument (IV 5 60 V). These
data have been normalized to the high pressure conditions by
accounting for differences in pressure, length, and voltage of the
injected-ion and high-pressure drift tubes. The middle spectrum
shows the ion mobility distribution obtained in the high-pressure
instrument when the capillary temperature is 300 K. The top
spectrum shows the distribution obtained at a capillary tempera-
ture of 450 K. All three data sets were normalized to a buffer gas
pressure of 180.00 torr and a drift field of 142.4 V cm21. The dotted
lines represent distributions calculated from eq. 4 for transport of
a single conformation of each species through the drift tube (see
text). Asterisks denote the locations of reproducible maxima in the
distributions.
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Figure 6. (a) Three-dimensional plot of drift time, flight time, and ion abundance for a distribution
of electrosprayed polyalanine ions measured by using the ion mobility/time-of-flight MS instrument
shown in Figure 2. The drift tube was operated by using a drift field of 11.8 V cm21, and 1.900 6 0.004
torr of He buffer gas. The data were recorded at an injection voltage of 70 V. The resolved peaks
correspond to [Alan1H]
1 peptides having n 5 5–30. (b) shows the same distribution at a slightly
different orientation. Here, the peaks observed in (a) comprise the single large peak on the right. This
orientation allows a second distribution of ions corresponding to [Ala2n12H]
21 and [Ala2n1112H]
21
dimer ions to be resolved. Fig. 6(c) shows a blow up of the three dimensional plot over the [Ala91H]
1
to [Ala121H]
1 size range. These data show TOF spectra associated with eleven distinct drift time
windows. Shaded peaks represent features at the same mass-to-charge ratios associated with
[Alan1H]
1 monomers and [Ala2n12H]
21 dimer ions. The brackets show the range of drift times
associated with these ions. The white peaks observed at mass-to-charge ratios between those for the
[Alan1H]
1 ions are because of [Ala2n1112H]
21 ions. The range of drift times associated with these
peaks is circled.
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Figure 7a,b,c shows the ion mobility/TOF distribu-
tion that is obtained when the mixture of ions is injected
into the drift tube at 280 V. At this injection voltage,
features in the data corresponding to the higher mobil-
ity doubly charged dimer ions are depleted and the
peaks assigned as singly charged polyalanine contain-
ing 5 to 30 residues remain. The size range of singly
charged alanine peptides ([Ala51H]
1 to [Ala301H]
1)
and distribution maximum (at [Ala121H]
1) are the
same as observed at an injection voltage of 70 V. This
indicates that peptide fragmentation across covalent
bonds is minimal. A final interesting feature of these
data is that smaller peptides appear to be favored at
high injection voltages. Presumably, these ions are
formed upon dissociation of larger doubly charged
aggregates.
Figure 7. Three-dimensional representation of drift time, flight time, and ion abundance for a
distribution of electrosprayed polyalanine ions injected into the drift tube by using 280 V. The data
were recorded by using a drift field of 11.8 V cm21 and a buffer gas pressure of 1.973 6 0.005 torr. (a),
(b), and (c) are the three orientations shown in Fig. 6.
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Discussion
Cross Sections for Monomer Ions
By using eq 2 and the data in Figure 3, we derive cross
sections of 239, 240, and 284 Å2 for the BK(11), BK(12),
and BK(13) ions. The 239 and 240 Å2 values determined
for BK(11) and BK(12) are similar to the 242 Å2 value
for BK(11) reported by Bowers and co-workers [25].
The BK(11) ion is believed to be stabilized by formation
of a gas-phase salt bridge where the C-terminal carbox-
ylic acid group is deprotonated and stabilized by inter-
actions with protonated Arg1 and Arg9 residues [53].
The BK(12) ion does not appear to form a salt bridge
and an extended conformation, which reduces Cou-
lomb repulsion energy has been proposed [53]. Al-
though we have not carried out detailed molecular
modeling studies for this system, the 240 Å2 cross
section for BK(12) indicates that this state is as compact
as the BK(11) ion. This ion may relieve some repulsive
forces by placing charges on opposite sides of the
compact form. The BK(13) ion has a cross section of 284
Å2, ;20% larger than the cross sections observed for the
compact BK(11) and BK(12) states. This ion cannot
form a salt bridge because all three basic sites (Arg1,
Arg9, and the N-terminal amino group) are protonated
during the ESI process, leaving the C-terminal carbox-
ylic acid group protonated. Without the salt bridge, the
peptide adopts more elongated conformations in order
to reduce the Coulomb repulsion energy.
Bowers and co-workers resolved a single peak for
BK(11) and noted that it was broader than the distri-
bution calculated for a single conformation [25]. Our
high-resolution ion mobility distribution shows shoul-
ders on both sides of the main features for the main
peak for BK(11), a result that requires that at least three
conformations are stable over the 20–30 ms time scale of
these experiments. The BK system has three basic sites
(Arg1, Arg9, and the N-terminal amino group) and a
single acidic site (the C-terminal carboxylic acid) that
give three different possible salt-bridge combinations.
All would involve interactions between both ends of the
peptide and thus lead to compact conformations. It is
possible that other compact structures that do not
involve a salt-bridge account for one or more of the
shoulders observed. In their thermal dissociation stud-
ies, Williams and co-workers have noted an induction
period prior to the onset of dissociation that they
postulated might be due to the time required for other
conformations to reach the dissociative state [53]. The
observation of three stable states in our data may help
explain the origin of the delay observed by Williams.
By using molecular modeling methods we have
generated several closely packed folded conformations,
conformers that are primarily a-helical, and near-linear
structures for each of the four peptides studied here.
These modeling methods were not as extensive as those
employed by Bowers for BK [25] or the approach used
in our DNA studies [54]. However, they provide a good
estimate of cross sections for compact and elongated
conformations and allow us to rapidly assess the nature
of conformations studied here. Overall, the best agree-
ment with the experimental data is found for trial
conformers that have compact (roughly spherical) con-
formations, such as those discussed above for BK(11)
and BK(12). Cross sections of 388 and 390 Å2 measured
for the ICA(22) and ICA(23) ions also appear to be
tightly packed (roughly spherical) forms. Trial elon-
gated a-helical and near-linear conformers have cross
sections that are factors of 1.2 6 0.1 and 1.5 6 0.1 times
larger than those estimated for compact conformations
of the peptides studied here. If the exact hard sphere
scattering model (which gives higher values) is used to
calculate cross sections, then conformations must be
even more tightly packed in order to match the exper-
imental cross sections.
Several of the highly charged peptide monomers do
not favor compact conformations. These include
BK(13) (discussed above) and ICA(24), that was
formed under some ESI conditions and has a cross
section of 470 Å2. These ions favored conformations that
are highly extended (between values we estimate for
trial helical and near-linear forms).
Assignment of Peaks II–IV for BK (m/z 5 1061)
and I–VI for ICA (m/z 5 2531)
Assuming peak I for ICA(21) corresponds to a singly
charged monomer, we derive a cross section of 390 Å2.
This value is the same as the 388 and 390 Å2 cross
sections derived for ICA(22) and ICA(23). Thus, from
the above discussion, ICA(21) must be a compact
conformation of the monomer peptide.
Attempts to create more compact forms of singly
charged monomer ions to assign to higher mobility ions
have been unsuccessful. This indicates that peaks II–VI
are due to more highly charged ions. In order to have
mass-to-charge ratios that are identical to the singly
charged monomers, these ions must have the general
formula [Mn1nH]
n1. Mobilities for multiply charged
multimers are determined by each multimer’s charge-
to-cross section ratio. In systems where the average
cross section per monomer unit decreases as the mono-
mers associate, the mobilities will sequentially increase
as the cluster size increases (as observed in Figures 3
and 4). Mobilities for peaks II, III, and IV are larger than
values for peak I by factors of 1.3 6 0.1, 1.5 6 0.1, and
1.7 6 0.1 for the systems studied here. Multiply charged
aggregates (containing a single charge per monomer)
are also expected to dissociate to form singly charged
peptides, with no obvious changes in mass spectral
distributions, consistent with the injection voltage stud-
ies (Figure 4). With the peaks assigned as multiply
charged multimers, we note that dissociation appears to
occur by sequential monomer loss, as there are no
favored multimer peaks at intermediate injection volt-
ages.
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To proceed further in the analysis of these systems,
we assumed that the cluster size corresponds to the
peak numbers. In most of the systems we have studied,
peaks are easily resolved and assigned by this ap-
proach. However, some ambiguities associated with
unresolved features, such as peaks III and IV (BK); V
and VI (ICA); and IV and V (LG7) exist. In all cases,
assignments have been made from multiple data sets. In
some of the ICA data, peaks V and VI were resolved to
baseline, clarifying this system. The assignments of
peaks III and IV for BK are considered in detail below.
The assignment of peak IV and peak V for LG7 (the
peak and shoulder shown in Figure 4) is ultimately
based on the similarities with the other peptides stud-
ied.
Figure 8 shows aggregate cross sections determined
from Eq 2 plotted against mass. Cross sections increase
systematically with increasing mass, suggesting that the
overall shapes of these aggregates are the same for all of
the peptides studied. Insight into the shapes of the
aggregates can be obtained by comparing the experi-
mental cross sections with several models. Figure 8 also
shows calculated collision cross sections for a variety of
trial aggregate structures, including systems of near-
linear and helical monomers attached end-to-end, bun-
dles of helical monomers in a closest packed arrange-
ment, and spherical monomers in a closest packed
arrangement. This analysis shows that elongated end-
to-end arrangements are much larger than any of the
ions observed experimentally. As discussed below,
these structures should reduce Coulomb repulsion of
the multiply charged systems, but allow for only a few
noncovalent binding interactions between monomers.
An excellent fit to the experimental data is obtained by
considering the cross section of a sphere of constant
density as a function of mass. By using the expression V
5 p[(3m/4pr)1/312.2/2]2 we derive an average ag-
gregate density of r 5 0.87 g cm23. This method of
analysis is essentially the projection model described
above, and thus the density obtained should be a good
lower limit to the true aggregate density. Cross sections
for trial aggregates, where spherical monomers are
arranged into tightly packed roughly spherical arrange-
ments, are also in good agreement with the experimen-
tal results. An upper limit to the average density can be
obtained by considering that the exact hard sphere
scattering model (applied to roughly spherical compact
conformers) typically yields cross sections that are
;15% larger than values obtained from the projection
approximation method. This brackets an upper limit for
the density as 1.00 g cm23. The 0.87 , r , 1.00 g cm23
density found here is somewhat below densities that
have been reported for biomolecules in solution [55].
A final note regarding this analysis involves cross
sections calculated for bundles of elongated conforma-
tions. Unlike cross sections for aggregates of elongated
conformers bound end-to-end (that diverge rapidly
from the experimental data with increasing size, Figure
8), bundles of elongated monomers bound side-to-side
are in poor agreement with the experimental data for
small multimers, but are in reasonable agreement for
large multimers. As the number of elongated mono-
mers in the bundle increases, the aggregate takes on a
compact three-dimensional structure. Side-to-side inter-
actions of elongated monomers provide numerous op-
portunities for noncovalent van der Waals and hydro-
gen bonding interactions that may stabilize the multiply
charged system. For example, b-sheet-like interactions
(that maximize hydrogen bonding between two aligned
peptides) may be favored for these types of structures.
Complications in Assignments of Aggregate
Cluster Size
Difficulties in peak assignments in these systems are
compounded by the possibility that highly charged
multimers could adopt elongated conformations in or-
der to reduce Coulomb repulsion. This type of behavior
has been observed for a number of multiply charged
protein systems [28, 29] and DNA [54]. We have con-
sidered this in some detail in order to avoid misassign-
ing peaks in these systems. A particularly difficult
system is BK. In Figure 5, peaks I and II contain
multiple stable conformations that have cross sections
that are near the values calculated for tightly packed
spherical forms. Thus, there is little ambiguity in assign-
Figure 8. Cross sections as a function of mass for monomers and
multimers of bradykinin (open squares), insulin chain A [proton-
ated (open circles) and deprotonated (filled circles)], LG6 (open
triangles), and LG7 (filled triangles). The cross section of the 14
state of cytochrome c is also shown (filled square). The solid line
represents cross sections calculated for spherical ions having a
density of 0.87 g cm23. Dashed, dotted-dashed, and dotted lines
show calculated cross sections assuming aggregate structures are
bundles of helices attached side-to-side, helices attached end-to-
end in series, and a series of extended strings for each of the
peptide systems. See text for discussion.
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ing features in peaks I and II as [M1nH]1 monomers
and [M212H]
21 dimers, respectively. However, none of
the features observed from ;18 to 25 ms in Figure 6
associated with peaks III and IV are resolved at base-
line, making the near continuum of peaks more difficult
to assign.
It is possible that all of the features observed over the
;18 to 26 ms range associated with peaks III and IV in
the BK system (Figure 5) are due to a range of different
conformations within a single multimer size (i.e., [M41
4H]41). The absence of [M313H]
31 would be consistent
with a formation process in which monomers aggregate
to forms dimers, and dimers aggregate to form tetram-
ers. In the present system, drift times of 22.8 and 23.7 ms
(for the features observed in peak III at high resolu-
tions) would have cross sections of ;650 and 700 Å2,
similar to values calculated for extended helical forms
of the tetramer (Figure 8). Extended forms of BK aggre-
gates may be especially stable if ionic interactions such
as salt-bridge structures between monomer units stabi-
lize the aggregates. In the end, based on the correlation
with other systems in Figure 8 and the dissociation data
in Figures 3 and 4 we believe the best assignment of the
broad feature observed for peak III is to the trimer ion
[M313H]
31.
Heterogeneous Aggregates of Different Peptide
Sizes of Polyalanine
The three-dimensional drift time and time-of-flight data
recorded for the mixture of different sizes of polyala-
nine peptides provides insight about the size specificity
of aggregate formation. The ability to record mass-to-
charge resolved mobility distributions simultaneously
in our ion mobility/TOF apparatus allows mobility and
mass-to-charge resolved abundance information for all
ions of the system to be directly measured. The cross
sections derived from these data for all sizes of [Alan1
H]1 peptides are consistent with values we have calcu-
lated for structures derived by detailed molecular mod-
eling studies and will be discussed elsewhere [56].




are no dramatic differences in abundance in these
peaks, which would be expected if specific sizes pref-
erentially formed aggregates. Further, the largest peak
in these distributions is observed for the [Ala2412H]
21
ion, near the largest [Ala121H]
1 peak observed for the
monomer. Thus, it appears that aggregates of polyala-
nine peptides associate according to the initial popula-
tions of peptide monomers. We note that within a
specific mass-to-charge ratio, the FWHM of the ion
mobility peak for doubly charged polyalanine aggre-
gates is larger than the FWHM observed for the singly
charged polyalanine monomer ions. In all of the indi-
vidual peptide ions that we have studied, FWHMs for
peak II are less than FWHMs for peak I, because of the
higher mobility and higher charge state of the multiply
charged multimer that leads to greater resolving power
(eq. 3). The apparent broadening of the doubly charged
dimer ions of polyalanine aggregates probably results
from the heterogeneity of the monomer sizes within the
different aggregate structures. For example, at m/z 5
872, the [Ala2412H]
21 ion could be formed from aggre-
gation of Ala101Ala14, Ala111Ala13, Ala121Ala12, etc.
Future high-resolution studies may clarify this.
Considerations of the Role of Solvents in Aggregate
Formation
Schey and co-workers have investigated multimer for-
mation as a function of initial solution concentration
and find that above a minimum threshold concentration
the fraction of multimers is essentially invariant [14].
Below this threshold, multimers are not observed. We
have monitored ion mobility distributions over a range
of concentrations (3 3 1025 to 1 3 1023 M) for BK and
ICA. There are no significant variations in the multimer
distribution. At concentrations below 3 3 1025 M, the
low abundance of m/z 5 1061 and 2531 ions (for BK
and ICA, respectively) precludes measurements of ion
mobility profiles.
Despite the lack of a concentration dependence, it is
unlikely that multiply charged aggregates are formed
by association of singly charged monomers in the gas
phase because of the long-range nature of the repulsive
Coulombic interactions [1, 23b]. Attractive van der
Waals and hydrogen bonding interactions that stabilize
the multimers will only become significant at short
interaction distances. Thus, solvent shielding of charges
should play an important role in formation of multiply
charged multimers, either in bulk solution or as the ESI
droplet dries [57].
Predicting the Stability of Multiply Charged
Multimers
The similarities between systems that we have observed
suggests that a general model that predicts the stability
of multiply charged peptides may be accessible by
considering Coulomb repulsion as a function of multi-
mer size. The solid lines in Figure 9 show Coulomb
repulsion energies that we have calculated for two to
eight charges placed on the surfaces of spheres of
varying cross section [58]. As expected, for a sphere of
a given size, the Coulomb energy increases with the
number of charges. For spheres of a given charge, the
Coulomb energy decreases as the size of the sphere
increases. Superimposed on these lines are symbols that
correspond to the experimentally measured cross sec-
tions for each of the [Mn1nH]
n1 multimers observed
for the different peptide systems. The average Coulomb
repulsion energy per monomer unit increases with
increasing multimer size for [Mn1nH]
n1 ions. As the
size of the individual monomer units become larger, the
stabilities of [Mn1nH]
n1 aggregates increase, and mul-
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timers should persist to larger sizes. Indeed, the maxi-
mum aggregate sizes n 5 4, 5, and 6 for the BK, LG7,
and ICA, respectively, increase with the number of
amino acids in each peptide (9, 17, and 21 for BK, LG7,
and ICA, respectively). As the number of monomer
units in the multimer increase, these ions become in-
creasingly unstable, placing a limit upon the maximum
possible [Mn1nH]
n1 size for each peptide.
Additional insight into the stability of these ions can
be seen by considering the cross sections and Coulomb
repulsion energies that are expected when an additional
[M1H]1 monomer is added to the largest [Mn1nH]
n1
aggregate observed experimentally. These multimers
were not observed experimentally and are assumed to
be unstable. Estimates of cross sections for spherical
forms of these ions can be obtained from Figure 8. Plots
of these values along the Coulomb curves in Figure 9
show that addition of a singly charged monomer to the
largest experimentally observed ion results in a multi-
mer that falls to the left of experimentally observed
values for all sizes of each of the systems studied. This
is expected if the binding interactions for a given area of
contact between monomer units are similar for each of
the peptides studied here. The resulting plot of species
that are observed and those species that are constructed
by addition of a monomer to the largest observed
multimer defines a boundary associated with the tran-
sition between stable and unstable multimers. Spherical
multimers with cross sections and charge states that fall
to the right of this boundary are expected to be stable,
whereas those on the left should be unstable. Highly
charged spherical aggregates such as [Mn1
(n11)H](n11)1 ions should be less stable than [Mn1
nH]n1 ions and should diminish more rapidly in inten-
sity with increasing size than [Mn1nH]
n1 multimers.
Multimers containing fewer charges than monomer
units (such as [Mn1(n21)H]
(n21)1) should extend to
larger sizes than the [Mn1nH]
n1 ions observed here.
Intrinsic to the arguments presented above is the
idea that the maximum multimer size is defined by each
ion’s stability in the gas phase. It is conceivable that
multimer size distributions are limited by kinetic con-
straints during the ESI process such as initial peptide
concentration. However, multimer size distributions for
[Mn1nH]
n1 appear to be independent of solution con-
centration, consistent with the idea that higher multim-
ers are not observed because they are inherently unsta-
ble.
A feeling for the utility of Figure 9 as a predictor of
peptide multimer stability can be obtained by consid-
ering multimer formation observed in MS studies by
others. The closest comparison comes from mass spec-
tra of several peptides measured by Schey [14]. Their
data show mass spectra that are comprised of large
fractions of [Mn1(n 21)H]
(n21)1 (n 5 2–7 for angio-
tensin I and n 5 2 and 3 for a NRKLLDIA–NH2
sequence) as well as other multimers as large as octam-
ers that contain only a few charges. As mentioned
above, in some of our data we have observed small
peaks corresponding to similar ICA ions. Assuming
that these ions are spherical, the data in Figure 8 can be
used to deduce collision cross sections that are also
shown in Figure 9. For these ions, the multimer order is
larger than the charge state and thus the ions have cross
sections that fall to the right of the stability boundary.
Several mass spectra show evidence for [Mn1(n
11)H](n11)1 (n 5 2–5 for renin substrate and n 5 3
and 4 for angiotensin I). The intensity variations in the
mass spectra are similar to those we have observed for
increasing multimer sizes of [Mn1nH]
n1 aggregates in
drift time distributions. Cross sections derived from
Figure 8 for these ions fall near the stability boundary in
Figure 9 because each multimer contains more charges
than monomer units.
Figure 9 fails to predict the stability of several higher
charge states of small multimers reported by Schey [14],
including: [M317H]
71 and [M419H]
91 for renin sub-
strate. If spherical, these ions would have cross sections
of 652 and 790 Å2, and fall far above the stability
Figure 9. The solid lines show calculated Coulomb energies as a
function of cross section for spheres containing two to eight
charges. Cross sections are plotted on the respective charge line
for experimentally observed multimers of protonated bradykinin
(open squares), insulin chain A [protonated (open circles) and
deprotonated (filled circles)], protonated LG6 (open triangles),
and deprotonated LG7 (filled triangles). We have included the
measured cross section for [M2–3H]
32 for ICA, which was a small
peak in the mass spectra for some experimental conditions. Also
shown are cross sections estimated for [M(n11)1(n11)H]
(n11)1
ions, where n corresponds to the number of monomer units
comprising the largest [Mn1nH]
n1 multimer observed experi-
mentally for each peptide system. These points are shown as an
“X” and correspond to ions that were not observed experimen-
tally. The X’s on the charge state 4 line represent the Coulomb
energy for the [M214H]
41 and [M314H]
41 ions of bradykinin,
that were also not observed experimentally. The open and solid
diamonds show cross sections (estimated from Figure 8) for
[Mn1(n 21)H]
(n21)1 and [Mn1(n 11)H]
n111 ions (respectively)
observed by Schey and co-workers [14]. The shaded diamonds




31 ions also estimated from Figure 8 for two
peptides. The solid squares show cross sections for the 14 and 15
charge states of cytochrome c, taken from [28b]. A broad shaded
region is used to illustrate a stability boundary that occurs at the
interface of species that are observed experimentally and those
that were not observed.
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boundary on the 7 and 9 charge lines (Figure 9). It is
worth noting that the mass spectral peak for [M31
7H]71 is exceedingly small (less than 2% of the largest
peak shown) and we are unable to find the [M4 z19H]
91
in the data they show [14]. It could be argued that these
ions are metastable and would not be observed on the
longer time scales of our measurements, or that these
ions have elongated structures and thus should not
follow the model. Figure 9 also fails to predict large
peaks observed for a number of highly charged dimers
including the [M2–7H]
72 ion of ICA and very highly
charged protein dimers such as the 120 to 124 states of
cytochrome c [7]. It is likely that these highly charged
ions do not have spherical conformations. Based on the
extended state reported above for ICA(24), we expect
extended conformers of the dimer 27 charge state. We
have measured cross sections for highly charged dimers
of cytochrome c. Comparison of experimental cross
sections for [Cytc2119H]
191 with trial dimers show that
these ions favor extended conformations [59], and col-
lision induced dissociation of [Cytc21nH]
n1 (where
n 5 18, 20, 22, and 24) leads to highly charged
monomers [7], which are known to favor extended
conformations [28a,b].
Comparison with Stability of Folded and Unfolded
Protein Ion Conformers
Protein [28, 29] and DNA [54] ions undergo distinct
structural transitions from folded to unfolded confor-
mations as the charge state of the ion increases in order
to reduce Coulomb repulsion energy. Extensive studies
of cytochrome c show that the 14 and 15 charge states
favor compact conformations. The cross sections for
these ions are shown in Figure 9 and fall within the
region of stability for a compact conformation. A com-
pact conformation of the 16 ion will fall along the
boundary, and a compact form of the 17 and higher
charge states should be unstable. Indeed, compact
forms of the 14 and 15 charge states are favored under
all injection energy conditions and appear to be stable
even at buffer gas temperatures of ;600 K [60]. Com-
pact states of the 16 and 17 ions can be observed, but
only at low injection energies [28(b)]. Studies at high
injection voltages (or at high buffer gas temperatures)
show that these states are metastable and more open
conformations are favored [60]. The stability curve
shown in Figure 9 provides an estimate of the transition
region from compact to elongated conformations that is
in good agreement with these experimental results. The
Coulomb transition observed for oligothymidine [54]
([T10 2 nH]
n2) is also predicted nicely by Figure 9.
Cross sections for [T10 2 2H]
22 and [T10 2 3H]
32 ions
are 447 6 5 and 446 6 5 Å2, respectively, and fall within
the stable region for the doubly and triply charged
lines. The 24, 25, and 26 charge states of DNA favor
extended conformations (with cross sections of 537 6 5,
627 6 6, and 641 6 6, respectively), consistent with the
predicted instability of these ions in Figure 9. From this
discussion, it appears that the energy associated with
stabilizing high order intermolecular interactions in
multimers is similar in magnitude required to stabilize
intramolecular interactions in biopolymers. However,
in the absence of covalent or strong ionic interactions,
these small aggregates dissociate when they are desta-
bilized.
Summary and Conclusions
Ion mobility techniques have been used to examine the
conformations of peptide ions formed by ESI. Under the
present experimental conditions (that are typical of
many ESI source configurations), peaks in the mass
spectra that nominally correspond to singly charged
monomer ions were found to be primarily comprised of
multiply charged multimers, having a single charge for
each monomer unit. Comparison of experimental cross
sections with calculated values for trial multimer con-
formations show that the multimers have tightly
packed conformations that are roughly spherical. We
have bracketed the density of these ions as 0.87 , r ,
1.00 g cm23, values that are slightly lower than typical
densities for biomolecules in solution [55]. High-resolu-
tion ion mobility studies show that there are favored
high-order conformations in the gas phase. These con-
formations appear to be stable over long time scales
(;0.03 s). Multimer dissociation can be induced by
collisional or thermal excitation. In all of the systems we
have studied it appears that the multimers dissociate
via loss of singly charged monomer units.
A model based on considerations of Coulomb repul-
sion energy between multiple charges on the surfaces of
spheres has been developed in order to predict the
stability of multiply charged multimers. This model
predicts that aggregates containing four charges be-
come unstable for species with cross sections below
;500 Å2. Aggregates containing five and six charges
appear to become unstable for species with cross sec-
tions smaller than ;650 and ;1150 Å2, respectively.
It is important to note that although multiply
charged multimers dominated the ion mobility distri-
butions for the nominal singly charged monomer ions,
the mass spectra recorded for these systems showed
little or no evidence for multimer formation. Our
present results show that multimer formation is favor-
able for a wide array of different peptides (at least
under our ESI source conditions). Thus, for fragmenta-
tion and reactivity studies of singly charged monomer
ions by mass spectrometric methods, careful measure-
ments of isotopic distributions should be made to
ensure the purity of the singly charged monomer ion.
Under conditions where multimers are observed, iso-
topes for the m/z 5 1061 ion of bradykinin could not
be resolved. Heated capillary inlets and energetic colli-
sions in interfacial pressure regions should also favor
the singly charged monomer, and should provide an
efficient means of dissociating the multiply charged
multimers.
757J Am Soc Mass Spectrom 1998, 9, 743–759 GASEOUS PEPTIDE AGGREGATES IN MASS SPECTRA
Acknowledgments
This work was supported by grants from the NSF (grant no.
CHE-9625199), NIH (grant no. 1R01GM55647-01), and an ASMS
Research Award generously provided by Finnigan MAT. We are
grateful to Professor Andrew Ellington for generously donating
the LG6 and LG7 peptides.
References
1. Meng, C. K.; Fenn, J. B. Org. Mass Spectrom. 1991, 26, 542–549.
2. Ganem, B.; Li, Y.-T.; Henion, J. D. J. Am. Chem. Soc. 1991, 113,
6294–6296.
3. Ganem, B.; Li, Y.-T.; Henion, J. D. J. Am. Chem. Soc. 1991, 113,
7818–7819.
4. Katta, V.; Chait, B. T. J. Am. Chem. Soc. 1991, 113, 8534–8535.
5. Baca, M.; Kent, S. B. H. J. Am. Chem. Soc. 1992, 114, 3992–3993.
6. Ganguly, A. K.; Pramanik, B. N.; Tsarbopoulos, A.; Covey,
T. R.; Huang, E.; Fuhrman, S. A. J. Am. Chem. Soc. 1992, 114.
7. Smith, R. D.; Light-Wahl, K. J., Winger, B. E.; Loo, J. A. Org.
Mass Spectrom. 1992, 27, 811–821.
8. Huang, E. C.; Pramanik, B. N.; Tsarbopoulos, A.; Reichert, P.;
Guanguly, A. K.; Trotta, P. P.; Nagabhushan, T. L.; Covey,
T. R. J. Am. Soc. Mass Spectrom. 1993, 4, 624–630.
9. Li, Y.-T.; Hsieh, Y.-L.; Henion, J. D.; Ganem, B. J. Am. Soc. Mass
Spectrom. 1993, 4, 631–637.
10. Light-Wahl, K. J.; Winger, B. E.; Smith, R. D. J. Am. Chem. Soc.
1993, 115, 5869–5870.
11. Smith, R. D.; Light-Wahl, K. J. Biol. Mass Spectrom. 1993, 22,
493–501.
12. Tang, X.; Brewer, C. R.; Saha, S.; Chernushevich, I, Ens, W.;
Standing, K. G. Rapid Commun. Mass Spectrom. 1994, 8, 750–
754.
13. Light-Wahl, K. J.; Schwartz, B. W.; Smith, R. D. J. Am. Chem.
Soc. 1994, 116, 5271–5278.
14. Busman, M.; Knapp, D. R.; Schey, K. L. Rapid Commun. Mass
Spectrom. 1994, 8, 211–216.
15. Schwartz, B. L.; Bruce, J. E.; Anderson, G. A.; Hofstadler, S. A.;
Rockwood, A. S.; Smith, R. D. Chilkoti, A.; Stayton, P. S. J. Am.
Soc. Mass Spectrom. 1995, 6, 459–465.
16. Schwartz, B. W.; Gale, D. C.; Smith, R. D. Chilkoti, A.; Stayton,
P. S. J. Mass Spectrom. 1995, 30, 1095–1102.
17. Loo, J. A. J. Mass Spectrom. 1995, 30, 180–183.
18. Green, M. K.; Penn, S. G.; Lebrilla, C. B. J. Am. Soc. Mass
Spectrom. 1995, 6, 1247–1251.
19. Robinson, C. V.; Chung, E. W.; Kragelund, B. B.; Knudsen, J.;
Aplin, R. T.; Poulsen, F. M.; Dobson, C. M. J. Am. Chem. Soc.
1996, 118, 8646–8653; Thomson, B. A. J. Am. Soc. Mass Spec-
trom. 1997, 8, 1053–1058.
20. Stefansson, M.; Sjoberg, P. J. R.; Markides, K. E. Anal. Chem.
1996, 68, 1792–1797.
21. Penn, S. G.; He, F.; Green, M. K.; Lebrilla, C. B. J. Am. Soc. Mass
Spectrom. 1997, 8, 244–252.
22. Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse,
C. M. Science 1989, 246, 64–71.
23. For recent reviews, see (a) Przybylski, M.; Glocker, M. O.
Angew. Chem. Int. Ed. Engl. 1996, 35, 806–826; (b) Smith, R. D.;
Bruce, J. E.; Wu, Q.; Lei, Q. P. Chem. Soc. Rev. 1997, 26, 191–202;
(c) Loo, J. A. Mass Spectrom. Rev. 1997, 16, 1–23.
24. Ion mobility spectrometry methods are discussed in the fol-
lowing references: (a) Hagen, D. F. Anal. Chem. 1979, 51,
870–874; (b) Tou, J. C.; Boggs, G. U. Anal. Chem. 1976, 48,
1351–1357; (c) Karpas, Z.; Cohen, M. J.; Stimac, R. M.; Wern-
lund, R. F. Int. J. Mass Spectrom. Ion Processes 1986, 74, 153–159;
(d) St. Louis, R. H.; Hill, H. H. Cr. Rev. Anal. Chem. 1990, 21,
321–355; (e) von Helden, G.; Hsu, M. T.; Kemper, P. R.;
Bowers, M. T. J. Chem. Phys. 1991, 95, 3835–3837; (f) Jarrold,
M. F. J. Phys. Chem. 1995, 99, 11–21.
25. von Helden, G.; Wyttenbach, T.; Bowers, M. T. Science 1995,
267, 1483–1485; Wyttenbach, T.; von Helden, G.; Bowers, M. T.
J. Am. Chem. Soc. 1996, 118, 8355–8364.
26. For recent reviews of ion mobility studies of biomolecules, see:
Clemmer, D. E.; Jarrold, M. F. J. Mass Spectrom. 1997, 32,
577–592; Liu, Y.; Valentine, S. J.; Counterman, A. E.; Hoag-
lund, C. S.; Clemmer, D. E. Anal. Chem. 1997, 69, 728A–735A.
27. Dugourd, Ph.; Hudgins, R. R.; Clemmer, D. E.; Jarrold, M. F.
Rev. Sci. Instrum. 1997, 68, 1122–1129.
28. (a) Clemmer, D. E.; Hudgins, R. R.; Jarrold, M. F. J. Am. Chem.
Soc. 1995, 117, 10141–10142; (b) Shelimov, K. B.; Clemmer,
D. E.; Hudgins, R. R.; Jarrold, M. F. J. Am. Chem. Soc. 1997, 119,
2240–2248; (c) Shelimov, K. B.; Jarrold, M. F. J. Am. Chem. Soc.
1997, 119, 9586–9587.
29. (a) Valentine, S. J.; Clemmer, D. E. J. Am. Chem. Soc. 1997, 119,
3558–3566; (b) Valentine, S. J.; Anderson, J.; Ellington, A. E.;
Clemmer, D. E. J. Phys. Chem. B 1997, 101, 3891–3900; (c)
Valentine, S. J.; Counterman, A. E.; Clemmer, D. E. J. Am. Soc.
Mass Spectrom. 1997, 8, 954–961.
30. Qin, J.; Chait, B. T. J. Am. Chem. Soc. 1995, 117, 5411–5412;
Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M.; Anal. Chem.
1996, 68, 850–858; Wilm, M.; Shevchenko, A.; Houthaeve, T.;
Breit, S.; Schweigerer, L.; Fotsis, T.; Mann, M. Nature 1996, 379,
466–469; Shevchenko, A.; Jensen, O. N.; Podtelejnikov, A. V.;
Sagliocco, F.; Wilm, M.; Vorm, O.; Mortensen, P.; Boucherie,
H.; Mann, M. Proc. Natl. Acad. Sci. USA 1996, 93, 14440–14445;
Figeys, D.; Ducret, A.; Yates, Y. R., III; Aebersold, R. Nat.
Biotechnol. 1996, 14, 1579–1583; Neubauer, G.; Gottschalk, A.;
Fabrizio, P.; Seraphin, B.; Luhrmann, R.; Mann, M. Proc. Natl.
Acad. Sci. USA 1997, 94, 385–390; Qin, J.; Fenyo¨, D.; Zhao, Y.;
Hall, W. W.; Chao, D. M.; Wilson, C. J.; Young, R. A.; Chait,
B. T. Anal. Chem. 1997, 69, 3995–4001.
31. Loo, J. A.; Edmonds, C. G.; Udseth, H. R.; Smith, R. D. Anal.
Chim. Acta 1990, 241, 167–173; Rockwood, A. L.; Busman, M.;
Udseth, H. R.; Smith, R. D. Rapid Commun. Mass Spectrom.
1991, 5, 582–585; Busman, M.; Rockwood, A. L.; Smith, R. D. J.
Phys. Chem. 1992, 96, 2397–2400; Senko, M. W.; Speir, J. P.;
McLafferty, F. W. Anal. Chem. 1994, 66, 2801–2808; Little, D. P.;
Speir, J. P.; Senko, M. W.; O’Connor, P. B.; McLafferty, F. W.
Anal. Chem. 1994, 66, 2809–2815; Marzluff, E. M.; Campbell, S.;
Rodgers, M. T.; Beauchamp, J. L. J. Am. Chem. Soc. 1994, 116,
7787–7796; Meot-Ner (Mautner), M.; Dongre´, A. R.; Somogyi,
A´.; Wysocki, V. H. Rapid Commun. Mass Spectrom. 1995, 9,
829–836; Price, W. D.; Schnier, P. D.; Williams, E. R. Anal.
Chem. 1996, 68, 859–866; Price, W. D.; Schnier, P. D.; Jockusch,
R. A.; Williams, E. R. J. Am. Chem. Soc. 1996, 118, 10640–10644.
32. Covey, T. R.; Douglas, D. J. J. Am. Soc. Mass Spectrom. 1993, 4,
616–623; Cox, K. A.; Julian, R. K.; Cooks, R. G.; Kaiser, R. E.
J. Am. Soc. Mass Spectrom. 1994, 5, 127–136; Chen, Y.-L.;
Collings, B. A.; Douglas, D. J. J. Am. Soc. Mass Spectrom. 1997,
8, 681–687; Collings, B. A.; Douglas, D. J. J. Am. Chem. Soc.
1996, 118, 4488–4489.
33. Kaltashov, I. A.; Fenselau, C. C. J. Am. Chem. Soc. 1995, 117,
9906–9910; Adams, J.; Strobel, F.; Reiter, A. J. Am. Soc. Mass
Spectrom. 1996, 7, 30–41; Kaltashov, I. A.; Fenselau, C. C.
Proteins 1997, 27, 165–170.
34. Sullivan, P. A.; Axelsson, J.; Altmann, S.; Quist, A. P.; Sunqvist,
B. U. R.; Reimann, C. T. J. Am. Soc. Mass Spectrom. 1996, 7,
329–341.
35. Winter, B. E.; Light-Wahl, K. J.; Rockwood, A. L.; Smith, R. D.
J. Am. Chem. Soc. 1992, 114, 5897–5898; Suckau, D.; Shi, Y.; Beu,
S. C.; Senko, M. W.; Quinn, J. P.; Wampler, F. M.; McLafferty,
F. W. Proc. Natl. Acad. Sci. USA 1993, 90, 790–793; Wood, T. D.;
Chorush, R. A.; Wampler, F. M.; Little, D. P.; O’Connor, P. B.;
McLafferty, F. W. Proc. Natl. Acad. Sci. USA 1995, 92, 2451–
758 COUNTERMAN ET AL. J Am Soc Mass Spectrom 1998, 9, 743–759
2454; Cassady, C. J.; Carr, S. R. J. Mass Spectrom. 1996, 31,
247–254.
36. Schnier, P. F.; Gross, D. S.; Williams, E. R. J. Am. Chem. Soc.
1995, 117, 6747–6757; Williams, E. R. J. Mass Spectrom. 1996, 31,
831–842.
37. Rodriguez-Cruz, S. E.; Klassen, J. S.; Williams, E. R. J. Am. Soc.
Mass Spectrom. 1997, 8, 565–568.
38. Fye, J. L.; Woenckhaus, J.; Jarrold, M. F. J. Am. Chem. Soc., 1998,
120, 1327–1328.
39. Jarrold, M. F.; Honea, E. C.; J. Phys. Chem. 1991, 95, 9181–9185;
Jarrold, M. F.; Constant, V. A. Phys. Rev. Lett. 1991, 67,
2994–2997.
40. Liu, Y.; Clemmer, D. E. Anal. Chem. 1997, 69, 2504–2509.
41. Wittmer, D.; Chen, Y. H.; Luckenbill, B. K.; Hill, H. H., Jr. Anal.
Chem. 1994, 66, 2348–2355; Chen, Y. H.; Hill, H. H., Jr.;
Wittmer, D. P. Int. J. Mass Spectrom. Ion Processes 1996, 154,
1–13; Hudgins, R. R.; Woenckhaus, J.; Jarrold, M. F. Int. J. Mass
Spectrom. Ion Processes 1997, 165/166, 497–507; Guevremont, R.;
Siu, K. W. M.; Wang, J.; Ding, L. Anal. Chem. 1997, 69,
3959–3965.
42. Equipotential lines were calculated using: SIMION 3D, Idaho
National Engineering Laboratory, Idaho Falls, ID, 1994.
43. Hoaglund, C. S.; Valentine, S. J.; Sporleder, C. R.; Reilly, J. P.;
Clemmer, D. E., Anal. Chem., in press.
44. Insulin chain A has the sequence GIVEQZZASVZSLYQLE-
NYZN, where Z corresponds to an oxidized cysteine residue.
45. Mason, E. A.; McDaniel, E. W. Transport Properties of Ions in
Gases. Wiley: New York, 1988.
46. Mesleh, M. F.; Hunter, J. M.; Shvartsburg, A. A.; Schatz, G. C.;
Jarrold, M. F. J. Phys. Chem. 1996, 100, 16082–16086; Wytten-
bach, T.; von Helden, G.; Batka, J. J., Jr.; Carlat, D.; Bowers,
M. T. J. Am. Soc. Mass Spectrom. 1997, 8, 275–282.
47. Shvartsburg, A. A.; Jarrold, M. F. Chem. Phys. Lett. 1996, 261,
86–91.
48. Revercomb, H. E.; Mason, E. A. Anal. Chem. 1975, 47, 970.
49. Under low field conditions, the diffusion constant is related to
the measured mobility by the expression D 5 KkbT/ze, where
K is the mobility, kb is Boltzmann’s constant, and ze is the
charge.
50. The peak at m/z 5 500 for BK was not observed in other mass
spectra recorded under identical conditions and is probably a
noise spike.
51. Recent studies of the bradykinin system in our ion mobility/
TOF instrument show that at high injection voltages doubly
charged [M12H]21 ions may convert into singly charged
[M1H]1 ions. This presumably occurs at high injection volt-
ages via an endothermic process that forms HeH1.
52. As shown in eq 3, the theoretical resolving power increases as
the square root of the ion charge state.
53. Schnier, P. D.; Price, W. D.; Jockusch, R. A.; Williams, E. R.
J. Am. Chem. Soc. 1996, 118, 7178–7189.
54. Hoaglund, C. S.; Liu, Y.; Pagel, M.; Ellington, A. D.; Clemmer,
D. E. J. Am. Chem. Soc. 1997, 119, 9051–9052.
55. Handbook of Biochemistry and Molecular Biology, 3rd ed; Fasman,
G. D., Ed.; Cleveland, OH: Chem. Rubber, 1975; pp 429;
Methods in Enzymology, vol. 259; Johnson, M. L.; Ackers, G. K.,
Eds.; New York: Academic, 1995; pp 385.
56. Counterman, A. E.; Samuelson, S.; Martyna, G. J.; Clemmer,
D. E., unpublished.
57. The mechanism associated with ion formation during the final
stages of ESI is an area of active debate. Two models that have
been discussed are the charged residue model (Dole, M.;
Mack, L. L.; Hines, R. L.; Mobley, R. C.; Fergusson, L. P.; Alice,
M. B. J. Chem. Phys. 1968, 49, 2240–2249) and the ion evapo-
ration model (Iribarne, V.; Thompson, B. A. J. Chem. Phys.
1976, 64, 2287–2294).








where e0 is the permittivity of free space, and e is the dielectric
constant, and rij is the distance between charges assigned to
the i and j locations. Charges were assigned to locations that
minimize the Coulomb energy for a sphere containing from 2
to 8 charges. The dielectric constant is unknown; therefore, we
have used a value of 2.0, as reported for gas-phase cytochrome
c in [36].
59. Valentine, S. J.; Clemmer, D. E., unpublished results.
60. Woenckhaus, J.; Hudgins, R. R.; Jarrold, M. F., unpublished.
759J Am Soc Mass Spectrom 1998, 9, 743–759 GASEOUS PEPTIDE AGGREGATES IN MASS SPECTRA
